Thomas H. Cartwright

14.7k citations

81 papers · 11.2k indexed · 1 hit paper · h-index 25

Impact in

Oncology top 0.1%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis

Papers in

Oncology 70
- Colorectal Cancer Treatments and Studies 50
- Cancer Treatment and Pharmacology 43
- Colorectal Cancer Surgical Treatments 12
- Pancreatic and Hepatic Oncology Research 10
Hepatology 8
- Hepatocellular Carcinoma Treatment and Prognosis 8

Co-authors: Fairooz F. Kabbinavar W. Heim William Novotny Herbert I. Hurwitz John D. Hainsworth Louis Fehrenbacher Jordan Berlin Eric Holmgren
Journals: Journal of Clinical Oncology (37 papers)Clinical Colorectal Cancer (8 papers)Journal of Oncology Practice (8 papers)Annals of Oncology (3 papers)Cancer (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Thomas H. Cartwright

81 papers receiving 10.9k citations

Hit Papers

align trajectories log scale

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer 2004 · 8.4k citations

Peers

Countries citing papers authored by Thomas H. Cartwright

Since Specialization

Citations

This map shows the geographic impact of Thomas H. Cartwright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas H. Cartwright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas H. Cartwright more than expected).

Fields of papers citing papers by Thomas H. Cartwright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas H. Cartwright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas H. Cartwright. The network helps show where Thomas H. Cartwright may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas H. Cartwright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas H. Cartwright Line = papers co-authored together Thomas H. Cartwright links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting Drugs - Real World Outcomes ·Thomas H. Cartwright, Monika Parisi, Janet L. Espirito, Thomas W. Wilson, Corey Pelletier, Manish Patel, Hani M. Babiker	2018	33
2	Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials Annals of Oncology ·Daniel G. Haller, M. J. OʼConnell, Thomas H. Cartwright, Chris Twelves, Edward McKenna, Weijing Sun, Muhammad Wasif Saif, Renato Ramos Silva, Greg Yothers, Hans‐Joachim Schmoll	2015	84
3	Epidemiology and natural history of central venous access device use and infusion pump function in the NO16966 trial British Journal of Cancer ·Edward Chu, D.G. Haller, Thomas H. Cartwright, Chris Twelves, Jim Cassidy, Weijing Sun, Muhammad Wasif Saif, M Shapiro, J.H. Kim, Hans‐Joachim Schmoll	2014	6
4	Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials The Lancet Oncology ·Hans‐Joachim Schmoll, Chris Twelves, Weijing Sun, Michael J. O’Connell, Thomas H. Cartwright, Edward McKenna, Muhammad Wasif Saif, Steve Lee, Greg Yothers, Daniel G. Haller	2014	117
5	Florida Initiative for Quality Cancer Care: Improvements in Breast Cancer Quality Indicators During a 3-Year Interval Journal of the American College of Surgeons ·Christine Laronga, Jhanelle E. Gray, Erin M. Siegel, Ji‐Hyun Lee, William J. Fulp, Sook Eom, Fred Schreiber, R. H. Brown, Richard M. Levine, Thomas H. Cartwright, Guillermo Abesada‐Terk, George Kim, Carlos Alemany, Douglas Faig, Phillip A. Sharp, Merry Jennifer Markham, David Shibata, Mokenge P. Malafa, Paul B. Jacobsen	2014	12
6	Florida Initiative for Quality Cancer Care: Improvements on Colorectal Cancer Quality of Care Indicators during a 3-Year Interval Journal of the American College of Surgeons ·Erin M. Siegel, Paul B. Jacobsen, Ji‐Hyun Lee, Mokenge P. Malafa, William J. Fulp, Sook Eom, Dong-Won Kim, R. H. Brown, Richard M. Levine, Thomas H. Cartwright, Guillermo Abesada‐Terk, George Kim, Carlos Alemany, Douglas Faig, Jerry W. Huntley, Merry Jennifer Markham, David Shibata	2013	20
7	Adverse Events Associated With Antiangiogenic Agents in Combination With Cytotoxic Chemotherapy in Metastatic Colorectal Cancer and Their Management Clinical Colorectal Cancer ·Thomas H. Cartwright	2013	10
8	A Randomized, Phase II Trial of Standard Triweekly Compared with Dose-Dense Biweekly Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer: XELOX-A-DVS (Dense Versus Standard) The Oncologist ·Herbert I. Hurwitz, Edith P. Mitchell, Thomas H. Cartwright, И Г Гатауллин, Sylvia Hu, Edward McKenna, Yehuda Z. Patt	2012	11
9	Survival Outcomes of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Treated in US Community Oncology Clinical Colorectal Cancer ·Thomas H. Cartwright, Yeun Mi Yim, Elaine Yu, Mengchu Lin, N. Doda-Gashi, 宇賀健一郎	2012	28
10	Treatment Decisions After Diagnosis of Metastatic Colorectal Cancer Clinical Colorectal Cancer ·Thomas H. Cartwright	2011	77
11	Dosing Considerations for Capecitabine-Irinotecan Regimens in the Treatment of Metastatic and/or Locally Advanced Colorectal Cancer American Journal of Clinical Oncology ·Thomas H. Cartwright, David McCollum, Kristi A. Boehm	2010	3
12	Evaluating the quality of psychosocial care in outpatient medical oncology settings using performance indicators Psycho-Oncology ·Paul B. Jacobsen, David Shibata, Erin M. Siegel, Ji‐Hyun Lee, William J. Fulp, Carlos Alemany, Guillermo Abesada‐Terk, R. H. Brown, Thomas H. Cartwright, Douglas Faig, George Kim, Richard M. Levine, Merry Jennifer Markham, Fred Schreiber, Jerry W. Huntley, Mokenge P. Malafa	2010	47
13	Patients With Locally Advanced and Metastatic Colorectal Cancer Treated With Capecitabine Versus 5-Fluorouracil as Monotherapy or Combination Therapy With Oxaliplatin: A Cost Comparison Clinical Colorectal Cancer ·Edward Chu, Kathy L. Schulman, Edward McKenna, Thomas H. Cartwright	2010	14
14	Successful Administration of Panitumumab Alone After Severe Infusion Reaction to Cetuximab in a Patient with Metastatic Colorectal Cancer Clinical Colorectal Cancer ·Thomas H. Cartwright, Emma del Rosario Hernández Bezanilla	2008	12
15	Results of a Phase II Open-Label Study of Capecitabine in Combination with Irinotecan as First-Line Treatment for Metastatic Colorectal Cancer Clinical Colorectal Cancer ·Thomas H. Cartwright, James Joves, Svetislava J. Vukelja, Carlos A. Encarnacion, Kristi A. Boehm, Lina Asmar	2005	29
16	Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab Journal of Surgical Oncology ·Frank A. Scappaticci, Louis Fehrenbacher, Thomas H. Cartwright, John D. Hainsworth, W. Heim, Jordan Berlin, Fairooz F. Kabbinavar, William Novotny, Somnath Sarkar, Herbert I. Hurwitz	2005	396
17	Bevacizumab does not increase bleeding in patients with metastatic colorectal cancer receiving concurrent anticoagulation Journal of Clinical Oncology ·J. Hambleton, William Novotny, Herbert I. Hurwitz, Louis Fehrenbacher, Thomas H. Cartwright, John D. Hainsworth, W. Heim, Jordan Berlin, Fairooz F. Kabbinavar, Eric Holmgren	2004	45
18	Traumatic rupture of an aortic ulcerative atherosclerotic plaque producing aortic dissection: A complication of interscapular back blows used to dislodge objects from the esophagus Clinical Cardiology ·Diana L. Patterson, Johannes Gutenburg, Thomas H. Cartwright, Walter W. Jolly, 坪田欣也, Bruce F. Waller	1993	12
19	Hypoglycaemic Effect ofMomordica charantiaExtracts Planta Medica ·Caroline Day, Thomas H. Cartwright, Jean Provost, Clifford J. Bailey	1990	120
20	Arrhythmia and late mortality after Mustard and Senning operation for transposition of the great arteries Journal of Thoracic and Cardiovascular Surgery ·John Deanfield, A. John Camm, F J Macartney, Thomas H. Cartwright, John S. Douglas, Pambayun Kinasih Yekti Nastiti, Marc De Leval, J. Stark	1988	104

About Thomas H. Cartwright

Thomas H. Cartwright is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Cancer Research and Dermatology, having authored 81 papers that have together received 11.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (50 papers), Cancer Treatment and Pharmacology (43 papers), Gastric Cancer Management and Outcomes (16 papers), Colorectal Cancer Surgical Treatments (12 papers), Pancreatic and Hepatic Oncology Research (10 papers), Economic and Financial Impacts of Cancer (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). The work is most often cited by research in Oncology (7.3k citations), Hepatology (2.0k citations), Cancer Research (1.9k citations), Pulmonary and Respiratory Medicine (3.0k citations) and Pathology and Forensic Medicine (1.1k citations). Thomas H. Cartwright has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Fairooz F. Kabbinavar, W. Heim, William Novotny, Herbert I. Hurwitz, John D. Hainsworth, Louis Fehrenbacher, Jordan Berlin, Eric Holmgren, Ari David Baron and Gwen Fyfe. Their work appears in journals such as Journal of Clinical Oncology, Clinical Colorectal Cancer, Journal of Oncology Practice, Annals of Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact